Evidence for simvastatin anti-inflammatory actions based on quantitative analyses of NETosis and other inflammation/oxidation markers

Results in Immunology

Volumn 4, Issue 1, 2014, Pages 14-22

  Al Ghoul, Walid M ^a   Kim, Margarita S ^a   Fazal, Nadeem ^a   Azim, Anser C ^a   Ali, Ashraf ^a  

^a CHICAGO STATE UNIVERSITY   (United States)

Author keywords

Burn; Gut permeability; Mucosal barrier; NETs; Sepsis; SIRS; Statin

Indexed keywords

BIOLOGICAL MARKER; CARBONYL DERIVATIVE; CELL PROTEIN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GRANULOCYTE 1 PROTEIN; MELATONIN; MYELOPEROXIDASE; NUCLEIC ACID; PICOGREEN; SIMVASTATIN; UNCLASSIFIED DRUG; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD SAMPLING; BURN; COLON; COLON MUCOSA; CONTROLLED STUDY; DRUG EFFICACY; ELECTRIC RESISTANCE; ENTERITIS; FLOW CYTOMETRY; ILEUM; ILEUM MUCOSA; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTESTINE MUCOSA; MALE; MEASUREMENT; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHIL EXTRACELLULAR TRAP; NONHUMAN; OXIDATIVE STRESS; PERITONEUM LAVAGE; PLASMA; PRIORITY JOURNAL; PROTEIN CARBONYLATION; QUANTITATIVE ANALYSIS; SCALD; THERMAL INJURY; TISSUE HOMOGENATE; TRANSEPITHELIAL ELECTRICAL RESISTANCE; ANIMAL CELL; ANIMAL MODEL; CELLULAR PARAMETERS; DRUG EFFECT; EXTRACELLULAR TRAP; GRANULOCYTE; INTESTINE INJURY; MICROSCOPY;

EID: 84901228813     PISSN: None     EISSN: 22112839     Source Type: Journal    
DOI: 10.1016/j.rinim.2014.03.001     Document Type: Article

References (60)

1. Al-Ghoul W.M., Abu-Shaqra S., Park B.G. Melatonin plays a protective role in postburn rodent gut pathophysiology. International Journal of Biological Sciences 2010, 6(3):282-293. http://www.ncbi.nlm.nih.gov/pubmed/20567497.
2. Akcan A., Kucuk C., Sozuer E., et al. Melatonin reduces bacterial translocation and apoptosis in trinitrobenzene sulphonic acid-induced colitis of rats. World Journal of Gastroenterology 2008, 14(6):918-924. http://www.ncbi.nlm.nih.gov/pubmed/18240350, 10.3748/wjg.14.918.
3. Sener G., Tuǧtepe H., Velioǧlu-Oǧün? A. Melatonin prevents neutrophil-mediated oxidative injury in Escherichia coli-induced pyelonephritis in rats. Journal of Pineal Research 2006, 41(3):220-227. http://www.ncbi.nlm.nih.gov/pubmed/16948782, 10.1111/j.1600-079X.2006.00357.x.
4. Sener G., Sehirli A.O., Satiroǧlu H. Melatonin improves oxidative organ damage in a rat model of thermal injury. Burns: Journal of the International Society for Burn Injuries 2002, 28(5):419-425. http://www.ncbi.nlm.nih.gov/pubmed/12163279, 10.1016/S0305-4179(02)00053-0.
5. Maher B.M., Ni Dhonnchu T., Burke J.P. Statins alter neutrophil migration by modulating cellular Rho activity-a potential mechanism for statins-mediated pleotropic effects?. Journal of Leukocyte Biology 2009, 85:186-193. http://www.ncbi.nlm.nih.gov/pubmed/18840670.
6. Lee J.Y., Kim J.S., Kim J.M. Simvastatin inhibits NF-kappaB signaling in intestinal epithelial cells and ameliorates acute murine colitis. International immunopharmacology 2007, 7(2):241-248. http://www.ncbi.nlm.nih.gov/pubmed/17178392, 10.1016/j.intimp.2006.10.013.
7. Souza Neto J.L., Araújo-Filho I., Rego A.C., et al. Effects of simvastatin in abdominal sepsis in rats. Acta Cirúrgica Brasileira/Sociedade Brasileira Para Desenvolvimento Pesquisa Em Cirurgia 2006, 21(Suppl. 4):8-12. http://www.ncbi.nlm.nih.gov/pubmed/17293958, 10.1590/S0102-86502006001000003.
8. Pirat A., Zeyneloglu P., Aldemir D., et al. Pretreatment with simvastatin reduces Lung injury related to intestinal ischemia-reperfusion in rats. Anesthesia and Analgesia 2006, 102:225-232. http://www.ncbi.nlm.nih.gov/pubmed/16368834, 10.1213/01.ane.0000189554.41095.98.
9. Chello M., Mastroroberto P., Patti G., et al. Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass. Heart (British Cardiac Society) 2003, 89(5):538-543. http://www.ncbi.nlm.nih.gov/pubmed/12695460, 10.1136/heart.89.5.538.
10. Pruefer D., Makowski J., Schnell M., et al. Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation 2002, 106(16):2104-2110. http://www.ncbi.nlm.nih.gov/pubmed/12379581, 10.1161/01.CIR.0000034048.38910.91.
11. Diomede L., Albani D., Sottocorno M., et al. In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arteriosclerosis, Thrombosis, and Vascular Biology 2001, 21:1327-1332. http://www.ncbi.nlm.nih.gov/pubmed/11498461, 10.1161/hq0801.094222.
12. Pruefer D., Scalia R., Lefer A.M. Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arteriosclerosis, Thrombosis, and Vascular Biology 1999, 19(12):2894-2900. http://www.ncbi.nlm.nih.gov/pubmed/10591666, 10.1161/01.ATV.19.12.2894.
13. Fazal N., Shelip A., Siddiqui E., Ali A. Differential effector responses by circulating/blood and tissue/peritoneal neutrophils following burn combined with Enterococcus faecalis infection. FEMS Immunology and Medical Microbiology 2012, 64(2):191-204. http://www.ncbi.nlm.nih.gov/pubmed/22066701, 10.1111/j.1574-695X.2011.00881.x.
14. - production and intestinal edema following alcohol intoxication and burn injury. American Journal of Physiology. Gastrointestinal and Liver Physiology 2009, 297(2):G340-G347. http://www.ncbi.nlm.nih.gov/pubmed/19497959, 10.1152/ajpgi.00044.2009.
15. Gomez C.R., Nomellini V., Baila H. Comparison of the effects of aging and IL-6 on the hepatic inflammatory response in two models of systemic injury: scald injury versus i.p. LPS administration. Shock 2009, 31:178-184. http://www.ncbi.nlm.nih.gov/pubmed/18636046, 10.1097/SHK.0b013e318180feb8.
16. Choudhry M.A., Chaudry I.H. Alcohol, burn injury, and the intestine. Journal of Emergencies, Trauma, and Shock 2008, 1(2):81-87. http://www.ncbi.nlm.nih.gov/pubmed/19561986, 10.4103/0974-2700.43187.
17. Fazal N., Al-Ghoul W.M. Thermal injury-plus-sepsis contributes to a substantial deletion of intestinal mesenteric lymph node CD4 T cell via apoptosis. International Journal of Biological Sciences 2007, 3(6):393-401. http://www.ncbi.nlm.nih.gov/pubmed/17895960.
18. Fazal N., Raziuddin S., Khan M. Antigen presenting cells (APCs) from thermally injured and/or septic rats modulate CD4+ T cell responses of naive rat. Biochimica et Biophysica Acta 2006, 1762(1):46-53. http://www.ncbi.nlm.nih.gov/pubmed/16257513, 10.1016/j.bbadis.2005.07.005.
19. Al-Ghoul W.M., Khan M., Fazal N. Mechanisms of postburn intestinal barrier dysfunction in the rat: roles of epithelial cell renewal, E-cadherin, and neutrophil extravasation. Critical Care Medicine 2004, 32(8):1730-1739. http://www.ncbi.nlm.nih.gov/pubmed/15286551, 10.1097/01.CCM.0000132896.62368.01.
20. Fazal N., Shamim M., Khan S.S. Neutrophil depletion in rats reduces burn-injury induced intestinal bacterial translocation. Critical Care Medicine 2000, 28(5):1550-1555. http://www.ncbi.nlm.nih.gov/pubmed/10834710, 10.1097/00003246-200005000-00048.
21. phox proteins in neutrophils from burned rats. Shock (Augusta, Ga.) 1997, 8(4):256-260. http://www.ncbi.nlm.nih.gov/pubmed/9329126, 10.1097/00024382-199710000-00004.
22. Kolaczkowska E., Kubes P. Neutrophil recruitment and function in health and inflammation. Nature Reviews Immunology 2013, 13:159-175. http://www.ncbi.nlm.nih.gov/pubmed/23435331, 10.1038/nri3399.
23. Papayannopoulos V., Metzler K.D., Hakkim A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. Journal of Cell Biology 2010, 191(3):677-691. http://www.ncbi.nlm.nih.gov/pubmed/20974816.
24. Darrah E., Andrade F. NETs: the missing link between cell death and systemic autoimmune diseases?. Frontiers in Immunology 2012, 3(428):1-18. http://www.ncbi.nlm.nih.gov/pubmed/23335928.
25. Németh T., Mócsai A. The role of neutrophils in autoimmune diseases. Immunology Letters 2012, 143(1):9-19. http://www.ncbi.nlm.nih.gov/pubmed/22342996, 10.1016/j.imlet.2012.01.013.
26. Lögters T., Margraf S., Altrichter J., et al. The clinical value of neutrophil extracellular traps. Medical Microbiology and immunology 2009, 198:211-219. http://www.ncbi.nlm.nih.gov/pubmed/19653000, 10.1007/s00430-009-0121-x.
27. Lögters T., Paunel-Görgülü A., Zilkens C., et al. Diagnostic accuracy of neutrophil-derived circulating Free DNA (cf-DNA/NETs) for septic arthritis. Journal of Orthopaedic Research: Official Publication of the Orthopaedic Research Society 2009, 27:1401-1407. http://www.ncbi.nlm.nih.gov/pubmed/19422041, 10.1002/jor.20911.
28. Medina E. Neutrophil extracellular traps:a strategic tactic to defeat pathogens with potential consequences for the host. Journal of innate immunity 2009, 1:176-180. http://www.ncbi.nlm.nih.gov/pubmed/20375575, 10.1159/000203699.
29. Margraf S., Lögters T., Reipen J. Neutrophil-derived circulating Fredd DNA (CF-DNA/NETS):a potential prognostic marker for posttraumatic development of inflammatory second hit and sepsis. Shock 2008, 30(4):352-358. http://www.ncbi.nlm.nih.gov/pubmed/18317404, 10.1097/SHK.0b013e31816a6bb1.
30. Brinkmann V., Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nature Reviews Microbiology 2007, 5:577-582. http://www.ncbi.nlm.nih.gov/pubmed/17632569.
31. Fuchs T.A., Abed U., Goosmann C., et al. Novel cell death program leads to neutrophil extracellular traps. Journal of Cell Biology 2007, 176:231-241. http://www.ncbi.nlm.nih.gov/pubmed/17210947, 10.1083/jcb.200606027.
32. Brinkmann V., Reichard U., Goosmann C., et al. Neutrophil extracellular traps kill bacteria. Science 2004, 303(5663):1532-1535. http://www.ncbi.nlm.nih.gov/pubmed/15001782, 10.1126/science.1092385.
33. Van Avondt K., Fritsch-Stork R., Derksen R.H. Ligation of signal inhibitory receptor on leukocytes-1 suppresses the release of neutrophil extracellular traps in systemic lupus erythematosus. PLoS One 2013, 8(10):e78459. http://www.ncbi.nlm.nih.gov/pubmed/24205237, 10.1371/journal.pone.0078459.
34. Kaplan M.J., Radic M. Neutrophil extracellular traps: double-edged swords of innate immunity. Journal of Immunology 2012, 189(6):2689-2695. http://www.ncbi.nlm.nih.gov/pubmed/22956760, 10.4049/jimmunol.1201719.
35. Meng W., Paunel-Görgülü A., Flohé S., et al. Depletion of neutrophil extracellular traps in vivo results in hypersusceptibility to polymicrobial sepsis in mice. Critical Care 2012, 16(4):R137. http://www.ncbi.nlm.nih.gov/pubmed/22835277, 10.1186/cc11442.
36. Tillack K., Breiden P., Martin R. T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses. Journal of Immunology 2012, 188(7):3150-3159. http://www.ncbi.nlm.nih.gov/pubmed/22351936, 10.4049/jimmunol.1103414.
37. Dold S., Laschke M.W., Lavasani S. Simvastatin protects against cholestasis-induced liver injury. British Journal of Pharmacology 2009, 156:466-474. http://www.ncbi.nlm.nih.gov/pubmed/19154429, 10.1111/j.1476-5381.2008.00043.x.
38. Keshavarzian A., Banan A., Farhadi A., et al. Increases in free radicals and cytoskeletal protein oxidation and nitration in the colon of patients with inflammatory bowel disease. Gut 2003, 52(5):720-728. http://www.ncbi.nlm.nih.gov/pubmed/12692059, 10.1136/gut.52.5.720.
39. Ashley N.T., Weil Z.M., Nelson R.J. Inflammation: mechanisms, costs, and natural variation. Annual Review of Ecology, Evolution, and Systematics 2012, 43:385-406. 10.1146/annurev-ecolsys-040212-092530.
40. Crisby M. Modulation of the inflammatory process by statins. Drugs of Today 2003, 39(2):137-143. http://www.ncbi.nlm.nih.gov/pubmed/1582476212698208, 10.1358/dot.2003.39.2.740209.
41. Bereswill S., Muñoz M., Fischer A., et al. Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PloS One 2010, 5(12):e15099. http://www.ncbi.nlm.nih.gov/pubmed/21151942, 10.1371/journal.pone.0015099.
42. Jahovic N., Gedik N., Ercan F., et al. Effects of statins on experimental colitis in normocholesterolemic rats. Scandinavian Journal of Gastroenterology 2006, 41(8):954-962. http://www.ncbi.nlm.nih.gov/pubmed/16803694, 10.1080/00365520600554444.
43. Shishehbor M.H., Brennan M.-L., Aviles R.J., et al. Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 2003, 108:426-431. http://www.ncbi.nlm.nih.gov/pubmed/12860913, 10.1161/01.CIR.0000080895.05158.8B.
44. Bonab A.A., Carter E.A., Paul K., et al. Effect of simvastatin on burn-induced alterations in tissue specific glucose metabolism: implications for burn associated insulin resistance. International Journal of Molecular Medicine 2010, 26(3):311-316. http://www.ncbi.nlm.nih.gov/pubmed/20664945.
45. Zhao G., Yu Y.M., Kaneki M. Simvastatin protects hepatocytes from apoptosis by suppressing the TNF-α/caspase-3 signaling pathway in mice with burn injury. Annals of Surgery 2013, 257(6):1129-1136. http://www.ncbi.nlm.nih.gov/pubmed/23275311, 10.1097/SLA.0b013e318273fdca.
46. Mirza H., Wu Z., Teo J.D., Tan K.S. Statin pleiotropy prevents Rho kinase-mediated intestinal epithelial barrier compromise induced by blastocystis cysteine proteases. Cellular Microbiology 2012, 14(9):1474-1484. http://www.ncbi.nlm.nih.gov/pubmed/22587300, 10.1111/j.1462-5822.2012.01814.x.
47. Shibata H., Nishitani N., Yaohara S. Simvastatin represses translocation of Pseudomonas aeruginosa across Madin-Darby canine kidney cell monolayers. Journal of Medical Investigation 2012, 59(1-2):186-191. http://www.ncbi.nlm.nih.gov/pubmed/22450007.
48. McGown C.C., Brookes Z.L. Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide. British Journal of Anaesthesia 2007, 98(2):163-175. http://www.ncbi.nlm.nih.gov/pubmed/17251210, 10.1093/bja/ael358.
49. Fogerty M.D., Efron D., Morandi A. Effect of preinjury statin use on mortality and septic shock in elderly burn patients. Journal of Trauma 2010, 69(1):99-103. http://www.ncbi.nlm.nih.gov/pubmed/20622585, 10.1097/TA.0b013e3181df61b1.
50. Dobesh P.P., Klepser D.G., McGuire T.R. Reduction in mortality associated with statin therapy in patients with severe sepsis. Pharmacotherapy 2009, 29(6):621-630. http://www.ncbi.nlm.nih.gov/pubmed/19476415, 10.1592/phco.29.6.621.
51. Rinaldi B., Donniacuo M., Esposito E., et al. PPARα mediates the anti-inflammatory effect of simvastatin in an experimental model of zymosan-induced multiple organ failure. British Journal of Pharmacology 2011, 163:609-623. http://www.ncbi.nlm.nih.gov/pubmed/21323892, 10.1111/j.1476-5381.2011.01248.x.
52. Sathasivam S., Lecky B. Statin induced myopathy. British Medical Journal (Clinical Research Edition) 2008, 337:1159-1162. http://www.ncbi.nlm.nih.gov/pubmed/18988647.
53. Samraj R.S., Zingarelli B., Wong H.R. Role of biomarkers in sepsis care. Shock 2013, 40(5):358-365. http://www.ncbi.nlm.nih.gov/pubmed/24088989, 10.1097/SHK.0b013e3182a66bd6.
54. Development and validation of a model for prediction of mortality in patients with acute burn injury. British Journal of Surgery 2009, 96:111-117. Belgian Outcome in Burn Injury Study Group. http://www.ncbi.nlm.nih.gov/pubmed/19109825, 10.1002/bjs.6329.
55. Lorente J.A., Vallejo A., Galeiras R., et al. Organ dysfunction as estimated by the sequential organ failure assessment score is related to outcome in critically ill burn patients. Shock 2009, 31:125-131. http://www.ncbi.nlm.nih.gov/pubmed/18650779, 10.1097/SHK.0b013e31817fc3ef.
56. Tobiasen J., Hiebert J.M., Edlich R.F. The abbreviated burn severity index. Annals of Emergency Medicine 1982, 11:260-262. http://www.ncbi.nlm.nih.gov/pubmed/7073049, 10.1016/S0196-0644(82)80096-6.
57. Pham T.N., Kramer C.B., Wang J., et al. Epidemiology and outcomes of older adults with burn injury: an analysis of the National Burn Repository. Journal of Burn Care & Research: Official Publication of the American Burn Association 2009, 30:30-36. http://www.ncbi.nlm.nih.gov/pubmed/19060727, 10.1097/BCR.0b013e3181921efc.
58. Gomez M., Cartotto R., Knighton J. Improved survival following thermal injury in adult patients treated at a regional burn center. Journal of Burn Care & Research: Official Publication of the American Burn Association 2008, 29:130-137. http://www.ncbi.nlm.nih.gov/pubmed/18182910.
59. Farrell R.T., Gamelli R.L., Aleem R.F. The relationship of body mass index and functional outcomes in patients with acute burns. Journal of Burn Care & Research: Official Publication of the American Burn Association 2008, 29:102-108. http://www.ncbi.nlm.nih.gov/pubmed/18182905.
60. Schofield Z.V., Woodruff T.M., Halai R. Neutrophils - a key component of ischemia-reperfusion injury. Shock 2013, 40(6):463-470. http://www.ncbi.nlm.nih.gov/pubmed/24088997, 10.1097/SHK.0000000000000044.